Aarsland, D. and M. G. Kramberger (2015). "Neuropsychiatric symptoms in Parkinson’s disease." Parkinsons Dis. 5(3): 659-667. https://doi.org/10.3233/JPD-150604.
Abdelsalam, R. M. and M. M. Safar (2015). "Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE‐NF κB and Nrf2‐antioxidant signaling pathways." neurochemist. 133(5): 700-707. https://doi.org/10.1111/jnc.13087.
Aflaki, E., D. K. Borger, N. Moaven, B. K. Stubblefield, S. A. Rogers, S. Patnaik, F. J. Schoenen, W. Westbroek, W. Zheng and P. Sullivan (2016). "A new glucocerebrosidase chaperone reduces α-synuclein and glycolipid levels in iPSC-derived dopaminergic neurons from patients with Gaucher disease and parkinsonism." Neurosci. 36(28): 7441 -7452. https://doi.org/10.1523/JNEUROSCI.0636-16.2016.
Antunes, M. S., F. V. L. Ladd, A. A. B. L. Ladd, A. L. Moreira, S. P. Boeira and L. C. Souza (2021). "Hesperidin protects against behavioral alterations and loss of dopaminergic neurons in 6-OHDA-lesioned mice: the role of mitochondrial dysfunction and apoptosis." Metab Brain Dis. 36(1): 153-167. https://doi.org/10.1007/s11011-020-00618-y.
Auld, D. S., T. J. Kornecook, S. Bastianetto and R. Quirion (2002). "Alzheimer’s disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies." Prog neurobiol. 68(3): 209-245. https://doi.org/10.1016/S0301-0082(02)00079-5.
Bellampalli, S. S., Y. Ji, A. Moutal, S. Cai, E. K. Wijeratne, M. A. Gandini, J. Yu, A. Chefdeville, A. Dorame and L. A. Chew (2019). "Betulinic acid, derived from the desert lavender Hyptis emoryi, attenuates paclitaxel-, HIV-, and nerve injury-associated peripheral sensory neuropathy via block of N-and T-type calcium channels." Pain. 160(1): 117. https://dx.doi.org/10.1097%2Fj.pain.0000000000001385.
Betarbet, R., T. B. Sherer, G. MacKenzie, M. Garcia-Osuna, A. V. Panov and J. T. Greenamyre (2000). "Chronic systemic pesticide exposure reproduces features of Parkinson's disease." Nat Neurosci. 3(12): 1301-1306. http://neurosci.nature.com/.
Bhattacharya, S., A. Bhattacharya, A. Kumar and S. Ghosal (2000). "Antioxidant activity ofBacopa monniera in rat frontal cortex, striatum and hippocampus." Phytother Res. 14(3): 174-179. https://doi.org/10.1002/(SICI)1099-1573(200005)14:3%3C174::AID-PTR624%3E3.0.CO;2-O.
Bi, Y., J. Xu, X. Wu, W. Ye, S. Yuan and L. Zhang (2007). "Synthesis and cytotoxic activity of 17-carboxylic acid modified 23-hydroxy betulinic acid ester derivatives." Bioorg Med Chem Lett. 17(5): 1475-1478. https://doi.org/10.1016/j.bmcl.2006.09.096.
Bildziukevich, U., L. Rárová, D. Šaman and Z. Wimmer (2018). "Picolyl amides of betulinic acid as antitumor agents causing tumor cell apoptosis." Eur J Med Chem 145: 41-50. https://doi.org/10.1016/j.ejmech.2017.12.096.
Blandini, F., M.-T. Armentero and E. Martignoni (2008). "The 6-hydroxydopamine model: news from the past." Parkinsonism Relat Disord. 14: S124-S129. https://doi.org/10.1016/j.parkreldis.2008.04.015.
Blaževski, J., F. Petković, M. Momčilović, R. Paschke, G. N. Kaluđerović, M. M. Stojković and D. Miljković (2013). "Betulinic acid regulates generation of neuroinflammatory mediators responsible for tissue destruction in multiple sclerosis in vitro." Acta Pharmacol Sin. 34(3): 424-431. https://doi.org/10.1038/aps.2012.181.
Cai, P., J. Ye, J. Zhu, D. Liu, D. Chen, X. Wei, N. R. Johnson, Z. Wang, H. Zhang and G. Cao (2016). "Inhibition of endoplasmic reticulum stress is involved in the neuroprotective effect of bFGF in the 6-OHDA-induced Parkinson’s disease model." Aging Dis. 7(4): 336. https://dx.doi.org/10.14336%2FAD.2016.0117.
Chen, L., J. Liu, U. Ali, Z. H. Gui, C. Hou, L. L. Fan, Y. Wang and T. Wang (2011). "Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist produces anxiolytic-like effects and reverses abnormal firing activity of projection neurons in the basolateral nucleus of the amygdala in rats with bilateral 6-OHDA lesions." Brain Res Bull. 84(3): 215-223. https://doi.org/10.1016/j.brainresbull.2011.01.005.
Dash, S. K., S. Chattopadhyay, T. Ghosh, S. S. Dash, S. Tripathy, B. Das, B. G. Bag, D. Das and S. Roy (2015). "Self-assembled betulinic acid protects doxorubicin induced apoptosis followed by reduction of ROS–TNF-α–caspase-3 activity." Biomed Pharmacother. 72: 144-157. https://www.sciencedirect.com/science/journal/07533322/72/supp/C.
De Jesús-Cortés, H., A. D. Miller, J. K. Britt, A. J. DeMarco, M. De Jesús-Cortés, E. Stuebing, J. Naidoo, E. Vázquez-Rosa, L. Morlock and N. S. Williams (2015). "Protective efficacy of P7C3-S243 in the 6-hydroxydopamine model of Parkinson's disease." NPJ Parkinson's dis. 1(1): 1-6. https://doi.org/10.1038/npjparkd.2015.10.
Deng, G., C. Ma, H. Zhao, S. Zhang, J. Liu, F. Liu, Z. Chen, A. T. Chen, X. Yang and J. Avery (2019). "Anti-edema and antioxidant combination therapy for ischemic stroke via glyburide-loaded betulinic acid nanoparticles." Theranostics. 9(23): 6991. https://dx.doi.org/10.7150%2Fthno.35791.
Deng, Z., K. Purtell, V. Lachance, M. S. Wold, S. Chen and Z. Yue (2017). "Autophagy receptors and neurodegenerative diseases." Trends Cell Biol. 27(7): 491-504. https://doi.org/10.1016/j.tcb.2017.01.001.
do Nascimento, G. C., D. P. Ferrari, F. S. Guimaraes, E. A. Del Bel, M. Bortolanza and N. C. Ferreira-Junior (2020). "Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease." Neuropharmacology 163: 107808. https://doi.org/10.1016/j.neuropharm.2019.107808.
Dolatshahi, M., Y. Farbood, A. Sarkaki, S. M. T. Mansouri and A. Khodadadi (2015). "Ellagic acid improves hyperalgesia and cognitive deficiency in 6-hydroxidopamine induced rat model of Parkinson’s disease." Iran J Basic Med Sci. 18(1): 38.
Domenici, R. A., A. C. P. Campos, S. T. Maciel, M. B. Berzuino, M. S. Hernandes, E. T. Fonoff and R. L. Pagano (2019). "Parkinson's disease and pain: Modulation of nociceptive circuitry in a rat model of nigrostriatal lesion." Exp Neurol. 315: 72-81. https://doi.org/10.1016/j.expneurol.2019.02.007.
Faggiani, E., F. Naudet, M. L. Janssen, Y. Temel and A. Benazzouz (2018). "Serotonergic neurons mediate the anxiolytic effect of l-DOPA: neuronal correlates in the amygdala." Neurobiol Dis. 110: 20-28. https://doi.org/10.1016/j.nbd.2017.11.001.
Faivre, F., A. Joshi, E. Bezard and M. Barrot (2019). "The hidden side of Parkinson’s disease: Studying pain, anxiety and depression in animal models." Neurosci Biobehav. 96: 335-352. https://doi.org/10.1016/j.neubiorev.2018.10.004.
Farnsworth, N. R., O. Akerele, A. S. Bingel, D. D. Soejarto and Z. Guo (1985). "Medicinal plants in therapy." Bull World Health Organ. 63(6): 965.
Fine, J. M., B. M. Stroebel, K. A. Faltesek, K. Terai, L. Haase, K. E. Knutzen, J. Kosyakovsky, T. J. Bowe, A. K. Fuller and W. H. Frey (2020). "Intranasal delivery of low-dose insulin ameliorates motor dysfunction and dopaminergic cell death in a 6-OHDA rat model of Parkinson’s Disease." Neurosci Lett. 714: 134567. https://doi.org/10.1016/j.neulet.2019.134567.
Fleming, S. M., Y. Delville and T. Schallert (2005). "An intermittent, controlled-rate, slow progressive degeneration model of Parkinson’s disease: antiparkinson effects of Sinemet and protective effects of methylphenidate." Behav Brain Res. 156(2): 201-213. https://doi.org/10.1016/j.bbr.2004.05.024.
Goes, A. T., C. R. Jesse, M. S. Antunes, F. V. L. Ladd, A. A. L. Ladd, C. Luchese, N. Paroul and S. P. Boeira (2018). "Protective role of chrysin on 6-hydroxydopamine-induced neurodegeneration a mouse model of Parkinson's disease: Involvement of neuroinflammation and neurotrophins." Chem Biol Interact. 279: 111-120. https://doi.org/10.1016/j.cbi.2017.10.019.
Gonçalves, D. F., A. A. Courtes, D. D. Hartmann, P. C. da Rosa, D. M. Oliveira, F. A. Soares and C. L. Dalla Corte (2019). "6-Hydroxydopamine induces different mitochondrial bioenergetics response in brain regions of rat." Neurotoxicology 70: 1-11. https://doi.org/10.1016/j.neuro.2018.10.005.
Guo, J. D., X. Zhao, Y. Li, G. R. Li and X. L. Liu (2018). "Damage to dopaminergic neurons by oxidative stress in Parkinson's disease." Int J Mol Med. 41(4): 1817-1825. https://doi.org/10.3892/ijmm.2018.3406.
Han, C., H. Shen, Y. Yang, Y. Sheng, J. Wang, W. Li, X. Zhou, L. Guo, L. Zhai and Q. Guan (2020). "Antrodia camphorata polysaccharide resists 6‐OHDA‐induced dopaminergic neuronal damage by inhibiting ROS‐NLRP3 activation." Brain Behav. 10(11): e01824. https://doi.org/10.1002/brb3.1824.
Iancu, R., P. Mohapel, P. Brundin and G. Paul (2005). "Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice." Behav Brain Res. 162(1): 1-10. https://doi.org/10.1016/j.bbr.2005.02.023.
Jamila, N., M. Khairuddean, K. K. Yeong, H. Osman and V. Murugaiyah (2015). "Cholinesterase inhibitory triterpenoids from the bark of Garcinia hombroniana." J Enzyme Inhib Med Chem. 30(1): 133-139. https://doi.org/10.3109/14756366.2014.895720.
Jiao, S., H. Zhu, P. He and J. Teng (2016). "Betulinic acid protects against cerebral ischemia/reperfusion injury by activating the PI3K/Akt signaling pathway." Biomed Pharmacother . 84: 1533-1537. https://doi.org/10.1016/j.biopha.2016.11.028.
Kaundal, M., S. Zameer, A. K. Najmi, S. Parvez and M. Akhtar (2018). "Betulinic acid, a natural PDE inhibitor restores hippocampal cAMP/cGMP and BDNF, improve cerebral blood flow and recover memory deficits in permanent BCCAO induced vascular dementia in rats." Eur J Pharmacol. 832: 56-66. https://doi.org/10.1016/j.ejphar.2018.05.015.
Kelly, E., P. Jenner and C. Marsden (1984). "Behavioural effects mediated by unilateral nigral dopamine receptor stimulation in the rat." Exp Brain Res. 55(2): 243-252. https://doi.org/10.1007/BF00237275.
Kesh, S., R. R. Kannan and A. Balakrishnan (2021). "Naringenin alleviates 6-hydroxydopamine induced Parkinsonism in SHSY5Y cells and zebrafish model." Comp Biochem Physiol C: Toxicol Pharmacol. 239: 108893. https://doi.org/10.1016/j.cbpc.2020.108893.
Kim, J., Y. S. Lee, C. S. Kim and J. S. Kim (2012). "Betulinic acid has an inhibitory effect on pancreatic lipase and induces adipocyte lipolysis." Phytother Res. 26(7): 1103-1106. https://onlinelibrary.wiley.com/journal/10991573.
Lau, Y. S., G. Patki, K. Das‐Panja, W. D. Le and S. O. Ahmad (2011). "Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson’s disease with moderate neurodegeneration." Eur J Neurosci. 33(7): 1264-1274. https://doi.org/10.1111/j.1460-9568.2011.07626.x.
Lingaraju, M. C., N. N. Pathak, J. Begum, V. Balaganur, H. D. Ramachandra, R. A. Bhat, M. Ram, V. Singh, K. Kandasamy and D. Kumar (2015). "Betulinic acid attenuates renal oxidative stress and inflammation in experimental model of murine polymicrobial sepsis." Eur J Pharm Sci. 70: 12-21. https://doi.org/10.1016/j.ejps.2015.01.001.
Mansouri, M. T., Y. Farbood, M. J. Sameri, A. Sarkaki, B. Naghizadeh and M. Rafeirad (2013). "Neuroprotective effects of oral gallic acid against oxidative stress induced by 6-hydroxydopamine in rats." Food Chem. 138(2-3): 1028-1033. https://doi.org/10.1016/j.foodchem.2012.11.022.
Martin, J.-L. and C. Finsterwald (2011). "Cooperation between BDNF and glutamate in the regulation of synaptic transmission and neuronal development." Commun Integr Biol. 4(1): 14-16. https://doi.org/10.4161/cib.13761.
Nascimento, G., K. Bariotto-Dos-Santos, C. Leite-Panissi, E. Del-Bel and M. Bortolanza (2018). "Nociceptive response to l-DOPA-induced dyskinesia in hemiparkinsonian rats." Neurotox Res. 34(4): 799-807. https://doi.org/10.1007/s12640-018-9896-0.
Navabi, S. P., A. Sarkaki, E. Mansouri, M. Badavi, A. Ghadiri and Y. Farbood (2018). "The effects of betulinic acid on neurobehavioral activity, electrophysiology and histological changes in an animal model of the Alzheimer’s disease." Behav Brain Res. 337: 99-106. https://doi.org/10.1016/j.bbr.2017.10.002.
Oyebanji, B. O., A. B. Saba and O. A. Oridupa (2014). "Studies on the anti-inflammatory, analgesic and antipyrexic activities of betulinic acid derived from Tetracera potatoria." Afr J Tradit Complement Altern Med. 11(1): 30-33. https://doi.org/10.4314/ajtcam.v11i1.5.
Planchard, M. S., M. A. Samel, A. Kumar and V. Rangachari (2012). "The natural product betulinic acid rapidly promotes amyloid-β fibril formation at the expense of soluble oligomers." ACS Chem Neurosci. 3(11): 900-908. https://doi.org/10.1021/cn300030a.
Porro, C., A. Cianciulli and M. A. Panaro (2020). "The regulatory role of IL-10 in neurodegenerative diseases." Biomolecules 10(7): 1017. https://doi.org/10.3390/biom10071017.
Prakash, B., A. Surendran, V. R. Chandraprabha, A. Pettamanna and H. N. R. Nair (2018). "Betulinic acid, natural pentacyclic triterpenoid prevents arsenic-induced nephrotoxicity in male Wistar rats." Comp Clin Pathol. 27(1): 37-44. https://doi.org/10.1007/s00580-017-2548-6.
Prinssen, E. P., F. C. Colpaert and W. Koek (2002). "5-HT1A receptor activation and anti-cataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy." Eur J pharmacol. 453(2-3): 217-221. https://doi.org/10.1016/S0014-2999(02)02430-5.
Qin, X.-Y., S.-P. Zhang, C. Cao, Y. P. Loh and Y. Cheng (2016). "Aberrations in peripheral inflammatory cytokine levels in Parkinson disease: a systematic review and meta-analysis." JAMA neurol. 73(11): 1316-1324. https://doi.org/10.1001/jamaneurol.2016.2742.
Razavinasab, M., A. Shamsizadeh, M. Shabani, M. Nazeri, M. Allahtavakoli, M. Asadi‐Shekaari, S. Esmaeli‐Mahani and V. Sheibani (2013). "Pharmacological blockade of TRPV 1 receptors modulates the effects of 6‐OHDA on motor and cognitive functions in a rat model of P arkinson's disease." Fundam Clin Pharmacol. 27(6): 632-640. https://doi.org/10.1111/fcp.12015.
Real, C. C., P. C. Garcia and L. R. Britto (2017). "Treadmill exercise prevents increase of neuroinflammation markers involved in the dopaminergic damage of the 6-OHDA Parkinson’s disease model." J Mol Neurosci. 63(1): 36-49. https://doi.org/10.1007/s12031-017-0955-4.
Roohbakhsh, A., A. H. Moghaddam, R. Massoudi and M. R. Zarrindast (2007). "Role of dorsal hippocampal cannabinoid receptors and nitric oxide in anxiety like behaviours in rats using the elevated plus‐maze test." Clinical Exp Pharmacol Physiol. 34(3): 223-229. https://doi.org/10.1111/j.1440-1681.2007.04576.x.
Rosa, I., D. Di Censo, B. Ranieri, G. Di Giovanni, E. Scarnati, M. Alecci, A. Galante and T. M. Florio (2020). "Comparison between Tail Suspension Swing Test and Standard Rotation Test in revealing early motor behavioral changes and neurodegeneration in 6-OHDA hemiparkinsonian rats." Int J Mol Sci. 21(8): 2874. https://doi.org/10.3390/ijms21082874.
Sarkaki, A., Y. Farbood, M. Badavi, L. Khalaj, F. Khodagholi and G. Ashabi (2015). "Metformin improves anxiety-like behaviors through AMPK-dependent regulation of autophagy following transient forebrain ischemia." Metab brain dis. 30(5): 1139-1150. https://doi.org/10.1007/s11011-015-9677-x.
Schober, A. (2004). "Classic toxin-induced animal models of Parkinson’s disease: 6-OHDA and MPTP." Cell Tissue Res. 318(1): 215-224. https://doi.org/10.1007/s00441-004-0938-y.
Silva, F. S., P. J. Oliveira and M. F. Duarte (2016). "Oleanolic, Ursolic, and Betulinic Acids as Food Supplements or Pharmaceutical Agents for Type 2 Diabetes: Promise or Illusion?" J Agric Food Chem. 64(15): 2991-3008. https://doi.org/10.1021/acs.jafc.5b06021.
Souza, P., C. Rodrigues, A. Santiago, N. Lucas, G. G. Leitao and A. Galina Filho (2011). "Antioxidant activity of natural compounds of Stachytarpheta cayennensis by scavenger of mitochondrial reactive oxygen species." Rev Bras Farmacogn 21: 420-426. https://doi.org/10.1590/S0102-695X2011005000050.
Staudt, M. D., A. R. Di Sebastiano, H. Xu, M. Jog, S. Schmid, P. Foster and M. O. Hebb (2016). "Advances in Neurotrophic factor and cell-based therapies for Parkinson's disease: a mini-review." Gerontology. 62(3): 371-380. https://doi.org/10.1159/000438701.
Tadaiesky, M., P. Dombrowski, C. Figueiredo, E. Cargnin-Ferreira, C. Da Cunha and R. Takahashi (2008). "Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease." Neuroscience. 156(4): 830-840. https://doi.org/10.1016/j.neuroscience.2008.08.035.
Teixeira, M., C. Souza, A. Menezes, M. Carmo, A. Fonteles, J. Gurgel, F. Lima, G. Viana and G. Andrade (2013). "Catechin attenuates behavioral neurotoxicity induced by 6-OHDA in rats." Pharmacol Biochem Behav. 110: 1-7. https://doi.org/10.1016/j.pbb.2013.05.012.
Ungerstedt, U. (1968). "6-Hydroxy-dopamine induced degeneration of central monoamine neurons." Eur J Pharmacol. 5(1): 107-110. https://doi.org/10.1016/0014-2999(68)90164-7.
Uzar, E., H. Alp, M. U. Cevik, U. Fırat, O. Evliyaoglu, A. Tufek and Y. Altun (2012). "Ellagic acid attenuates oxidative stress on brain and sciatic nerve and improves histopathology of brain in streptozotocin-induced diabetic rats." Neurol Sci. 33(3): 567-574. https://doi.org/10.1007/s10072-011-0775-1.
Vieira, J. C. F., T. B. Bassani, R. M. Santiago, G. d. O. Guaita, J. M. Zanoveli, C. da Cunha and M. A. Vital (2019). "Anxiety-like behavior induced by 6-OHDA animal model of Parkinson’s disease may be related to a dysregulation of neurotransmitter systems in brain areas related to anxiety." Behav Brain Res. 371: 111981. https://doi.org/10.1016/j.bbr.2019.111981.
Wang, W., L. T. Nguyen, C. Burlak, F. Chegini, F. Guo, T. Chataway, S. Ju, O. S. Fisher, D. W. Miller and D. Datta (2016). "Caspase-1 causes truncation and aggregation of the Parkinson’s disease-associated protein α-synuclein." Proc Natl Acad Sci. 113(34): 9587-9592. https://doi.org/10.1073/pnas.1610099113.
Williams‐Gray, C. H., R. Wijeyekoon, A. J. Yarnall, R. A. Lawson, D. P. Breen, J. R. Evans, G. A. Cummins, G. W. Duncan, T. K. Khoo and D. J. Burn (2016). "S erum immune markers and disease progression in an incident P arkinson's disease cohort (ICICLE‐PD)." Mov Disord. 31(7): 995-1003. https://doi.org/10.1002/mds.26563.
Yi, J., R. Zhu, J. Wu, J. Wu and Z. Tan (2015). "Ameliorative effect of betulinic acid on oxidative damage and apoptosis in the splenocytes of dexamethasone treated mice." Int Immunopharmacol. 27(1): 85-94. https://doi.org/10.1016/j.intimp.2015.04.050.
Yogeeswari, P. and D. Sriram (2005). "Betulinic acid and its derivatives: a review on their biological properties." Curr Med Chem. 12(6): 657-666. https://doi.org/10.2174/0929867053202214.
Zeng, A. Q., Y. Yu, Y. Q. Yao, F. F. Yang, M. Liao, L. J. Song, Y. L. Li, Y. Yu, Y. J. Li, Y. L. Deng, S. P. Yang, C. J. Zeng, P. Liu, Y. M. Xie, J. L. Yang, Y. W. Zhang, T. H. Ye and Y. Q. Wei (2018). "Betulinic acid impairs metastasis and reduces immunosuppressive cells in breast cancer models." Oncotarget. 9(3): 3794-3804. https://dx.doi.org/10.18632%2Foncotarget.23376.